These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8129213)

  • 1. Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.
    Nathan RA; Bronsky EA; Dockhorn RJ; Kemp JP
    Ann Allergy; 1994 Mar; 72(3):209-16. PubMed ID: 8129213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol.
    Nathan RA; Bodman SF; Storms WW; Mingo TS
    Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of inhaled bitolterol mesylate via metered-dose inhaler in children with asthma.
    Bierman CW; Kemp JP; Nathan RA
    Ann Allergy Asthma Immunol; 1996 Jan; 76(1):27-35. PubMed ID: 8564625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.
    Kemp JP; Orgel HA; Grossman J; Reed CE; Tinkelman DG; Webb DR; Ziment I
    Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.
    Pinnas JL; Bhatt BD; Campbell SC; Kemp JP; Tinkelman DG
    Chest; 1987 Apr; 91(4):533-9. PubMed ID: 3549173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
    Orgel HA; Kemp JP; Tinkelman DG; Webb DR
    J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):55-62. PubMed ID: 3968329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma.
    Nathan RA; Bernstein IL; Bronsky EA; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Pinnas JL; Repsher LH
    J Allergy Clin Immunol; 1987 May; 79(5):822-9. PubMed ID: 3571773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
    White MV; Cruz-Rivera M; Walton-Bowen K
    Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm.
    Messina MS
    Adv Ther; 1995; 12(3):157-63. PubMed ID: 10155050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bronchodilator responses with bitolterol mesylate solution with the use of two different nebulizer systems in asthma.
    Kemp JP; Pinnas JL; Tinkelman DG; Meltzer EO; Campbell SC; Orgel HA; Welch MJ; Mingo TS
    J Allergy Clin Immunol; 1986 Mar; 77(3):509-15. PubMed ID: 3950254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
    Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
    J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
    Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
    J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study.
    LaForce C; Alexander M; Deckelmann R; Fabbri LM; Aisanov Z; Cameron R; Owen R; Higgins M
    Allergy; 2008 Jan; 63(1):103-11. PubMed ID: 18053019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients.
    Pinnas JL; Bernstein IL; Bronsky EE; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Nathan RA; Repsher LH; Bhatt BD
    J Allergy Clin Immunol; 1987 May; 79(5):768-75. PubMed ID: 3571768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
    Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL
    Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous versus intermittent nebulization of salbutamol in acute severe asthma: a randomized, controlled trial.
    Besbes-Ouanes L; Nouira S; Elatrous S; Knani J; Boussarsar M; Abroug F
    Ann Emerg Med; 2000 Sep; 36(3):198-203. PubMed ID: 10969220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bitolterol mesylate in exercise-induced asthma.
    Walker SB; Bierman CW; Pierson WE; Shapiro GG; Furukawa CT; Mingo TS
    J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):32-6. PubMed ID: 3944373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.